Ignite Creation Date:
2024-07-17 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06472245
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-06-07
Brief Title:
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Sponsor:
OSE Immunotherapeutics
Organization:
OSE Immunotherapeutics
Organization Data
Organization:
OSE Immunotherapeutics
Class:
INDUSTRY
Study ID:
OSE2101C302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
OSE Immunotherapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Exystat | OTHER |
| Genome Diagnostics GenDx | UNKNOWN |